Targeting bacteroides in the stool microbiome and response to treatment (Rx) with first-line VEGFTKI in metastatic renal cell carcinoma (mRCC).
- Resource Type
- Journal
- Source
JOURNAL OF CLINICAL ONCOLOGY ; FEB 20 2018, 36 6, 1p. Supplement: S- Subject
- Language
- English
- ISSN
- 15277755